329 results on '"Hardisson D"'
Search Results
2. Common non-synonymous SNPs associated with breast cancer susceptibility: Findings from the Breast Cancer Association Consortium
3. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
4. Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
5. OSNA Total Tumor Load for the Prediction of Axillary Involvement in Breast Cancer Patients: Should We use Different Thresholds According to the Intrinsic Molecular Subtype? MOTTO Study
6. Molecular characterization of ovarian cancer by gene-expression profiling
7. Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
8. One-step nucleic acid amplification (OSNA) of Sentinel Lymph Node in Early Stage Endometrial Cancer: Spanish Multicenter Study (ENDO-OSNA).
9. Detection of lymph node metastases using pooling method by One-Step Nucleic Acid Amplification (OSNA) assay in prostate cancer patients: Preliminary results
10. Squamous cell carcinoma of the breast
11. Detection of lymph node metastases using pooling method by One-Step Nucleic Acid Amplification (OSNA) assay in prostate cancer patients: Preliminary results
12. The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group For Ovarian Cancer Research (GEICO)
13. Localisation of COX-2 protein is different in breast ductal carcinoma and adjacent non-tumour ductal epithelium
14. Sarcomatoid carcinoma of the pyriform sinus with brain and subcutaneous metastases: an unusual metastatic spread pattern
15. 860P Redefining prognosis in early-stage high-grade endometrial cancer
16. 862P Prognostic role of CD3, CD4, CD8 and FOXP3 positive populations in early-stage endometrial carcinoma
17. 32P Comparison of fully automated microsatellite instability test to immunohistochemistry for mismatch repair protein expression in endometrial carcinoma
18. Bevacizumab in recurrent ovarian cancer: could it be particularly effective in patients with clear cell carcinoma?
19. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas
20. Comprehensive molecular genetic analysis reveals FGFR1 as a potential therapeutic target for lobular breast carcinomas
21. Breast Cancer Prognosis Determined by Gene Expression Profiling: A Quantitative Reverse Transcriptase Polymerase Chain Reaction Study
22. Versatile Electroanalytical Bioplatforms for Simultaneous Determination of Cancer-Related DNA 5-Methyl- and 5-Hydroxymethyl-Cytosines at Global and Gene-Specific Levels in Human Serum and Tissues
23. Fine needle aspiration cytology of mammary carcinoma with osteoclast-like giant cells
24. Factors related to nerve injury and hypocalcemia in thyroid gland surgery
25. New insights in β-tubulin sequence analysis in non-small cell lung cancer
26. Malignant fibrous histiocytoma of the lung in a child: An unusual neoplasm that can mimick inflammatory pseudotumour
27. Experience with Endopredict® implementation at La Paz Universitiy Hospital (2015–2018)
28. Is it always necessary to perform an axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer?
29. Análisis costo-beneficio del estudio anatomopatológico de las piezas de amigdalectomía en la población pediátrica
30. Rhabdomyomatosis of the newborn lung unassociated with other malformations
31. Retroperitoneal melanocytic schwannoma
32. Neural variant of fetal rhabdomyoma and naevoid basal cell carcinoma syndrome
33. E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium
34. E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium
35. E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium
36. Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer
37. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
38. Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
39. Micro-RNA profile in advanced metastatic breast cancer as a predictive tool for response to bevacizumab-paclitaxel
40. Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
41. EndoPredict molecular-clinicopathological hybrid score (EPclin) provides superior prognostic information compared to molecular scores alone: a report of two cases
42. Comparison of two-dimensional (2D)- and three-dimensional (3D)-culture models as drug testing platforms in GIST: experience with axitinib in vitro
43. P252 - Experience with Endopredict® implementation at La Paz Universitiy Hospital (2015–2018)
44. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
45. Role of placental barrier integrity in infection by Trypanosoma cruzi
46. Alterations in placental tropho-blasts of pregnant women with Chagas disease
47. Congenital transmission of protozoa: Placental infection by Trypanosoma cruzi
48. P236 Intraoperative predictive model for non-SLN metastasis using total tumor load assessed by OSNA
49. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
50. 99P - Micro-RNA profile in advanced metastatic breast cancer as a predictive tool for response to bevacizumab-paclitaxel
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.